Skip to main content

Find Clinical Trials

Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Not Yet Recruiting

Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

NCT07274384

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.

NCT07271602

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer

NCT06882174

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer

NCT07256509

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Minimal Residual Disease in Solid Malignancies

NCT07268469

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +30 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

NCT07246759

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +41 more
Locations: Heidelberg University Hospital Heidelberg, Germany

Intituto Europeo di Oncologia SRL Milan, Italy

Virgen Macarena University Hospital - Servicio Andaluz de Salud Seville, Spain

View Trial Details

Not Yet Recruiting

Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC

NCT07242274

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC

NCT07235306

Conditions: ALK, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT05393466

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Penfluridol for Relapsed/Refractory Small Cell Cancers

NCT07206563

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details